Jingmei Hsu MD

Hematologic Oncology

Physician

520 East 70th StreetStarr Pavilion, 3rd FloorNew York, NY 10021
Phone+1 646-962-7950

Dr. Hsu is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hsu's full profile Already have an account?

Summary

I am a board certified hematologist specializing stem cell transplant and cellular therapy. I completed my hematology/oncology fellowship at Hospital of University of Pennsylvania.

Education & Training

Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2008
State University of New York Downstate Medical Center College of MedicineClass of 2007

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 2008 - 2027
PA State Medical License 2008 - 2016
NJ State Medical License 2006 - 2010
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016

Publications & Presentations

PubMed

Epigenetic Priming with Azacitidine Prior to Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies.
Mohammad Alhomoud, Franco Castillo Tokumori, Nora Chokr, Joshua Fein, Daniel C Choi
Transplantation and Cellular Therapy. 2026-08-15
Racial and ethnic disparities in brain-to-vein time among patients receiving CD19 CAR-T cell therapy for relapsed/refractory DLBCL.
Neela Easton, Anna Alperovich, Alexandra Gomez-Arteaga, Sebastian Mayer, Nora Chokr
Bone Marrow Transplantation. 2026-07-22
Immunoglobulin replacement after chimeric antigen receptor T-cell therapy in large B-cell lymphoma with hypogammaglobulinaemia: Secondary Center for International Bloo...
Sarah Makhani, Thilan Tudor, Efrat Luttwak, Mohammad Alhomoud, Maher Abdul-Hay
British Journal of Haematology. 2026-07-22

Abstracts/Posters

Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34+ pr...
Jingmei Hsu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration
Jingmei Hsu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T Infusion
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant?
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Research Leaders Across New York State Form Empire State Cellular Therapy ConsortiumJuly 10th, 2025
First Woman to Receive Stem Cell Transplant for HIV Remains Virus-Free 5 Years LaterMarch 17th, 2023
Another Person Cured of HIV Disease - but It Is a Special CaseMarch 17th, 2023